Cite Filings / FULC / 0001193125-23-010269
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Fulcrum Therapeutics, Inc. · Filed 2023-01-18 · Acc 0001193125-23-010269

Documents 1

  • 424B5 Prospectus , d405392d424b5.htm

Around this filing

  • 2025-12-08 424B5 Prospectus
  • 2023-01-23 SC 13G/A Amended Statement of Ownership
  • 2023-01-18 8-K Material agreement · Other events
  • 2023-01-18 424B5 Prospectus
  • 2023-01-17 424B5 Prospectus
  • 2023-01-17 8-K Results of operations · Other events
  • 2023-01-13 4 Interim President & CEO sold 6,766 shares at $15.00 ($101,490)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d405392d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…